KIOCL Ltd: Intrinsic Value & Share Price Analysis

Last Updated: December 13, 2025, 8:18 am

All Competitor Stocks of KIOCL Ltd

Last Updated: August 20, 2025, 8:05 am

Below is a detailed analysis of the quarterly data for KIOCL Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 91.00 Cr.. The value appears to be declining and may need further review. It has decreased from 246.00 Cr. (Mar 2025) to 91.00 Cr., marking a decrease of 155.00 Cr..
• For Expenses, as of Jun 2025, the value is 133.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 287.00 Cr. (Mar 2025) to 133.00 Cr., marking a decrease of 154.00 Cr..
• For Operating Profit, as of Jun 2025, the value is -42.00 Cr.. The value appears to be declining and may need further review. It has decreased from -41.00 Cr. (Mar 2025) to -42.00 Cr., marking a decrease of 1.00 Cr..
• For OPM %, as of Jun 2025, the value is -46.00%. The value appears to be declining and may need further review. It has decreased from -17.00% (Mar 2025) to -46.00%, marking a decrease of 29.00%.
• For Other Income, as of Jun 2025, the value is 17.00 Cr.. The value appears strong and on an upward trend. It has increased from 16.00 Cr. (Mar 2025) to 17.00 Cr., marking an increase of 1.00 Cr..
• For Interest, as of Jun 2025, the value is 4.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 4.00 Cr..
• For Depreciation, as of Jun 2025, the value is 10.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 11.00 Cr. (Mar 2025) to 10.00 Cr., marking a decrease of 1.00 Cr..
• For Profit before tax, as of Jun 2025, the value is -38.00 Cr.. The value appears strong and on an upward trend. It has increased from -40.00 Cr. (Mar 2025) to -38.00 Cr., marking an increase of 2.00 Cr..
• For Tax %, as of Jun 2025, the value is -2.00%. The value appears to be increasing, which may not be favorable. It has increased from -7.00% (Mar 2025) to -2.00%, marking an increase of 5.00%.
• For Net Profit, as of Jun 2025, the value is -38.00 Cr.. The value appears to be declining and may need further review. It has decreased from -37.00 Cr. (Mar 2025) to -38.00 Cr., marking a decrease of 1.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is -0.62. The value appears to be declining and may need further review. It has decreased from -0.61 (Mar 2025) to -0.62, marking a decrease of 0.01.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Last Updated: October 15, 2025, 4:59 am

Last Updated: September 5, 2025, 9:05 am

Balance Sheet

Last Updated: December 4, 2025, 1:32 am

Below is a detailed analysis of the balance sheet data for KIOCL Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:

• For Equity Capital, as of Sep 2025, the value is 608.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 608.00 Cr..
• For Reserves, as of Sep 2025, the value is 1,051.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,104.00 Cr. (Mar 2025) to 1,051.00 Cr., marking a decrease of 53.00 Cr..
• For Borrowings, as of Sep 2025, the value is 185.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 193.00 Cr. (Mar 2025) to 185.00 Cr., marking a decrease of 8.00 Cr..
• For Other Liabilities, as of Sep 2025, the value is 364.00 Cr.. The value appears to be improving (decreasing). It has decreased from 404.00 Cr. (Mar 2025) to 364.00 Cr., marking a decrease of 40.00 Cr..
• For Total Liabilities, as of Sep 2025, the value is 2,208.00 Cr.. The value appears to be improving (decreasing). It has decreased from 2,309.00 Cr. (Mar 2025) to 2,208.00 Cr., marking a decrease of 101.00 Cr..
• For Fixed Assets, as of Sep 2025, the value is 933.00 Cr.. The value appears to be declining and may need further review. It has decreased from 953.00 Cr. (Mar 2025) to 933.00 Cr., marking a decrease of 20.00 Cr..
• For CWIP, as of Sep 2025, the value is 175.00 Cr.. The value appears strong and on an upward trend. It has increased from 169.00 Cr. (Mar 2025) to 175.00 Cr., marking an increase of 6.00 Cr..
• For Investments, as of Sep 2025, the value is 29.00 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Mar 2025) to 29.00 Cr., marking an increase of 29.00 Cr..
• For Other Assets, as of Sep 2025, the value is 1,071.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,188.00 Cr. (Mar 2025) to 1,071.00 Cr., marking a decrease of 117.00 Cr..
• For Total Assets, as of Sep 2025, the value is 2,208.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2,309.00 Cr. (Mar 2025) to 2,208.00 Cr., marking a decrease of 101.00 Cr..

Notably, the Reserves (1,051.00 Cr.) exceed the Borrowings (185.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for KIOCL Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is -3.37. This value is below the healthy minimum of 5. It has decreased from -1.37 (Mar 24) to -3.37, marking a decrease of 2.00.
• For Diluted EPS (Rs.), as of Mar 25, the value is -3.37. This value is below the healthy minimum of 5. It has decreased from -1.37 (Mar 24) to -3.37, marking a decrease of 2.00.
• For Cash EPS (Rs.), as of Mar 25, the value is -2.72. This value is below the healthy minimum of 3. It has decreased from -0.91 (Mar 24) to -2.72, marking a decrease of 1.81.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 28.16. It has decreased from 31.57 (Mar 24) to 28.16, marking a decrease of 3.41.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 28.16. It has decreased from 31.57 (Mar 24) to 28.16, marking a decrease of 3.41.
• For Dividend / Share (Rs.), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 1. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 9.72. It has decreased from 30.51 (Mar 24) to 9.72, marking a decrease of 20.79.
• For PBDIT / Share (Rs.), as of Mar 25, the value is -2.47. This value is below the healthy minimum of 2. It has decreased from -0.36 (Mar 24) to -2.47, marking a decrease of 2.11.
• For PBIT / Share (Rs.), as of Mar 25, the value is -3.12. This value is below the healthy minimum of 0. It has decreased from -0.81 (Mar 24) to -3.12, marking a decrease of 2.31.
• For PBT / Share (Rs.), as of Mar 25, the value is -3.37. This value is below the healthy minimum of 0. It has decreased from -1.05 (Mar 24) to -3.37, marking a decrease of 2.32.
• For Net Profit / Share (Rs.), as of Mar 25, the value is -3.37. This value is below the healthy minimum of 2. It has decreased from -1.37 (Mar 24) to -3.37, marking a decrease of 2.00.
• For PBDIT Margin (%), as of Mar 25, the value is -25.45. This value is below the healthy minimum of 10. It has decreased from -1.18 (Mar 24) to -25.45, marking a decrease of 24.27.
• For PBIT Margin (%), as of Mar 25, the value is -32.14. This value is below the healthy minimum of 10. It has decreased from -2.66 (Mar 24) to -32.14, marking a decrease of 29.48.
• For PBT Margin (%), as of Mar 25, the value is -34.72. This value is below the healthy minimum of 10. It has decreased from -3.43 (Mar 24) to -34.72, marking a decrease of 31.29.
• For Net Profit Margin (%), as of Mar 25, the value is -34.64. This value is below the healthy minimum of 5. It has decreased from -4.49 (Mar 24) to -34.64, marking a decrease of 30.15.
• For Return on Networth / Equity (%), as of Mar 25, the value is -11.95. This value is below the healthy minimum of 15. It has decreased from -4.34 (Mar 24) to -11.95, marking a decrease of 7.61.
• For Return on Capital Employeed (%), as of Mar 25, the value is -9.59. This value is below the healthy minimum of 10. It has decreased from -2.31 (Mar 24) to -9.59, marking a decrease of 7.28.
• For Return On Assets (%), as of Mar 25, the value is -8.93. This value is below the healthy minimum of 5. It has decreased from -3.41 (Mar 24) to -8.93, marking a decrease of 5.52.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. It has decreased from 0.01 (Mar 24) to 0.00, marking a decrease of 0.01.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.00. This value is within the healthy range. It has decreased from 0.03 (Mar 24) to 0.00, marking a decrease of 0.03.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.24. It has decreased from 0.68 (Mar 24) to 0.24, marking a decrease of 0.44.
• For Current Ratio (X), as of Mar 25, the value is 3.56. This value exceeds the healthy maximum of 3. It has decreased from 4.42 (Mar 24) to 3.56, marking a decrease of 0.86.
• For Quick Ratio (X), as of Mar 25, the value is 3.17. This value exceeds the healthy maximum of 2. It has increased from 2.87 (Mar 24) to 3.17, marking an increase of 0.30.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 0.55. This value is below the healthy minimum of 4. It has decreased from 4.75 (Mar 24) to 0.55, marking a decrease of 4.20.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Interest Coverage Ratio (X), as of Mar 25, the value is -9.86. This value is below the healthy minimum of 3. It has decreased from -1.54 (Mar 24) to -9.86, marking a decrease of 8.32.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is -12.41. This value is below the healthy minimum of 3. It has decreased from -4.84 (Mar 24) to -12.41, marking a decrease of 7.57.
• For Enterprise Value (Cr.), as of Mar 25, the value is 13,610.10. It has decreased from 23,263.52 (Mar 24) to 13,610.10, marking a decrease of 9,653.42.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 23.05. This value exceeds the healthy maximum of 3. It has increased from 12.55 (Mar 24) to 23.05, marking an increase of 10.50.
• For EV / EBITDA (X), as of Mar 25, the value is -90.55. This value is below the healthy minimum of 5. It has increased from -1,056.84 (Mar 24) to -90.55, marking an increase of 966.29.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 24.28. This value exceeds the healthy maximum of 3. It has increased from 12.76 (Mar 24) to 24.28, marking an increase of 11.52.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Price / BV (X), as of Mar 25, the value is 8.38. This value exceeds the healthy maximum of 3. It has decreased from 12.33 (Mar 24) to 8.38, marking a decrease of 3.95.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 24.28. This value exceeds the healthy maximum of 3. It has increased from 12.76 (Mar 24) to 24.28, marking an increase of 11.52.
• For EarningsYield, as of Mar 25, the value is -0.01. This value is below the healthy minimum of 5. It has decreased from 0.00 (Mar 24) to -0.01, marking a decrease of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness